D27.505.954.122.388

4 trials

Sponsors

Blade Therapeutics Inc, Faculdade De Odontologia de Ribeirão Preto, Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo - HCFMRP-USP, Vice-Presidência de Pesquisa e Coleções Biológicas - VPPCB

Conditions

Coronavirus infectionsHerpetic StomatitisRespiratory Syncytial Virus Infectionsnew coronavirus infection

Phase 1

Clinical study to assess the safety, and tolerability of multiple doses of orally administered JNJ-53718678 in infants hospitalized with RSV infection

Active, not recruitingRBR-5497s9

Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo - HCFMRP-USPRespiratory Syncytial Virus Infections

Start: 2015-11-01Updated: 2025-10-27

Phase 2

Gel for the treatment of herpes lip lesions

RecruitingRBR-4kkq8c

Faculdade De Odontologia de Ribeirão PretoHerpetic Stomatitis

Start: 2017-03-10Updated: 2025-10-27

A phase 2 randomized double-blind placebo-controlled study to evaluate safety of BLD-2660 and its activity against COVID-19 virus in hospitalized subjects recently diagnosed with COVID-19 in comparison to standard of care treatment

RecruitingRBR-2kjm6y

Blade Therapeutics Incnew coronavirus infection

Start: 2020-05-22Updated: 2025-10-27

Phase 3

Evaluation with Favipiravir in patients with COVID-19

Active, not recruitingRBR-85vh8fx

Vice-Presidência de Pesquisa e Coleções Biológicas - VPPCBCoronavirus infections

Start: 2022-05-10Updated: 2025-10-27